Related Experiment Video
Updated: May 4, 2026
High Content Screening in Neurodegenerative Diseases
Published on: January 6, 2012
DJ-1 deficiency triggers microglia sensitivity to dopamine toward a pro-inflammatory phenotype that is attenuated by
Dorit Trudler1, Orly Weinreb, Silvia A Mandel
1Department of Neurobiology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel; Sagol School of Neuroscience, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
Abstract:
DJ-1 is an oxidative stress sensor that localizes to the mitochondria when the cell is exposed to oxidative stress. DJ-1 mutations that result in gene deficiency are linked to increased risk of Parkinson's disease (PD). Activation of microglial stress conditions that are linked to PD may result in neuronal death. We postulated that DJ-1 deficiency may increase microglial neurotoxicity. We found that down-regulation of DJ-1 in microglia using an shRNA approach increased cell sensitivity to dopamine as measured by secreted pro-inflammatory cytokines such as IL-1β and IL-6. Furthermore, we discovered that DJ-1-deficient microglia had increased monoamine oxidase activity that resulted in elevation of intracellular reactive oxygen species and nitric oxide leading to increased dopaminergic neurotoxicity. Rasagaline, a monoamine oxidase inhibitor approved for treatment of PD, reduced the microglial pro-inflammatory phenotype and significantly reduced neurotoxicity. Moreover, we discovered that DJ-1-deficient microglia have reduced expression of triggering receptor expressed on myeloid cells 2 (TREM2), previously suggested as a risk factor for pro-inflammation in neurodegenerative diseases. Further studies of DJ-1-mediated cellular pathways in microglia may contribute useful insights into the development of PD providing future avenues for therapeutic intervention
Insights
DJ-1 deficiency in microglia increases neurotoxicity, a risk factor for Parkinson's disease (PD). Treatment with Rasagaline, a PD drug, reduced this microglial neurotoxicity.
Area of Science:
- Neuroscience
- Cell Biology
- Molecular Biology
Background:
- DJ-1 is an oxidative stress sensor linked to Parkinson's disease (PD) risk.
- Microglial activation under stress contributes to neurodegeneration in PD.
- DJ-1 deficiency may exacerbate microglial-mediated neurotoxicity.
Purpose of the Study:
- To investigate the role of DJ-1 deficiency in microglial neurotoxicity.
- To explore the mechanisms by which DJ-1 impacts microglial function.
- To assess the therapeutic potential of targeting DJ-1 pathways in PD.
Main Methods:
- Down-regulation of DJ-1 in microglia using shRNA.
- Measurement of pro-inflammatory cytokines (IL-1β, IL-6) and monoamine oxidase (MAO) activity.
- Assessment of reactive oxygen species (ROS), nitric oxide (NO), and dopaminergic neurotoxicity.
- Evaluation of triggering receptor expressed on myeloid cells 2 (TREM2) expression.
Main Results:
- DJ-1 down-regulation increased microglial sensitivity to dopamine and pro-inflammatory cytokine release.
- DJ-1-deficient microglia exhibited increased MAO activity, elevated ROS and NO, and enhanced dopaminergic neurotoxicity.
- Rasagaline treatment reduced microglial pro-inflammation and neurotoxicity.
- DJ-1 deficiency correlated with reduced TREM2 expression in microglia.
Conclusions:
- DJ-1 deficiency promotes microglial neurotoxicity through increased oxidative stress and inflammation.
- Targeting DJ-1-mediated pathways in microglia offers a potential therapeutic strategy for Parkinson's disease.
- Reduced TREM2 expression in DJ-1-deficient microglia may contribute to their pro-inflammatory phenotype.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
01:24Parkinson Disease l: Introduction
01:24Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
01:15Parkinson's Disease: Overview
01:29Drugs Affecting Neurotransmitter Synthesis